That's why this company is flawed for the small shareholder. It is constantly being diluted, and then again when the CEOs etc are retiring, diluted again.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025